| Financial Year |
March 31 2023 |
| Monetary Funds |
27,279,974.40 |
| Held-for-trading Financial Assets |
6,320,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
945,747,450.08 |
| Advances to Suppliers |
229,908,851.15 |
| Other Receivables |
207,016,375.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
9,048,051.75 |
| Inventories |
55,779,016.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
299,976,585.46 |
| Total Current Assets |
1,772,028,252.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
641,969,132.49 |
| Investment Properties |
11,653,099.52 |
| Fixed Assetes |
691,557,659.85 |
| Under-construction Projects |
638,816,002.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
141,843,920.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,553,459.26 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
555,903.29 |
| Sub-Total of Non-Current Assets |
2,151,953,144.58 |
| Total Assets |
3,923,981,397.41 |
| Short-Term Loans |
2,698,763,881.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
284,020,354.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,335,646.72 |
| Taxes Payable |
1,324,803.86 |
| Interest Payable |
547,319,322.89 |
| Dividend Payable |
14,210,000.00 |
| Other payables |
716,161,015.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,031,715,690.27 |
| Other Current Liabilities |
2,220,428.83 |
| Sub-Total of Current Liabilities |
4,756,194,521.28 |
| Long-term Loans |
-- |
| Bonds Payable |
735,889,895.78 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
73,583,175.23 |
| Deferred Income Tax Liabilities |
3,956,910.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
815,218,762.14 |
| Total Liabilities |
5,571,413,283.42 |
| Paid-In Capital(Or Share Stock) |
3,051,878,231.00 |
| Capital Surplus |
744,302,035.02 |
| Surplus Reserve |
169,124,068.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,707,946,907.09 |
| Minority Stockholder's Interest |
27,423,365.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,674,855,251.76 |
| Owner's Equity（Stockholder's Equity） |
-1,647,431,886.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,923,981,397.41 |
